Table 1 Demographic and clinical characteristics of COVID-19 patients included in the study (n = 439)
From: Comorbidities and outcomes among patients hospitalized with COVID-19 in Upper Egypt
All patients (n = 439) | Patients without comorbidity (n = 168) | Patients with comorbidities (n = 271) | P-value | |
|---|---|---|---|---|
Age (years) | ||||
18–39 | 122 (27.8%) | 96 (57.1%) | 26 (9.6%) | < 0.001 |
40–59 | 147 (33.5%) | 51 (30.4%) | 96 (35.4%) | |
60–79 | 153 (34.9%) | 19 (11.3%) | 134 (49.4%) | |
≥ 80 | 17 (3.9%) | 2 (1.2%) | 15 (5.5%) | |
Mean ± SD | 51.2 ± 17.2 | 39.4 ± 15.0 | 58.5 ± 14.0 | < 0.001 |
Gender, n (%) | ||||
Male | 224 (51%) | 86 (51.2%) | 138 (50.9%) | 0.956 |
Female | 215 (49%) | 82 (48.8%) | 133 (49.1%) | |
Presenting symptoms, n (%) | ||||
Fever | 326 (74.3%) | 118 (70.2%) | 208 (76.8%) | 0.129 |
Constitutional symptoms, n (%) | 177 (40.3%) | 55 (32.7%) | 122 (45.0%) | 0.011 |
Fatigue | 125 (28.5%) | 42 (25%) | 83 (30.6%) | 0.204 |
Bone pain | 18 (4.1%) | 7 (4.2%) | 11 (4.1%) | 0.956 |
Myalgia | 63 (14.4%) | 17 (10.1%) | 46 (17%) | 0.045 |
Anorexia | 48 (10.9%) | 12 (7.1%) | 36 (13.3%) | 0.051 |
URT symptoms, n (%) | 110 (25.1%) | 37 (22%) | 73 (26.9%) | 0.248 |
Sore throat | 96 (21.9%) | 31 (18.5%) | 65 (24%) | 0.173 |
Nasal congestion | 24 (5.5%) | 11 (6.5%) | 13 (4.8%) | 0.433 |
LRT symptoms, n (%) | 328 (74.7%) | 113 (67.3%) | 215 (79.3%) | 0.005 |
Cough | 293 (66.7%) | 105 (62.5%) | 188 (69.4%) | 0.137 |
Sputum | 116 (26.4%) | 24 (14.3%) | 92 (33.9%) | < 0.001 |
Dyspnea | 208 (47.4%) | 51 (30.4%) | 157 (57.9%) | < 0.001 |
GIT symptoms, n (%) | 93 (21.2%) | 36 (21.4%) | 57 (21%) | 0.922 |
Abdominal pain | 11 (3.5%) | 6 (3.6%) | 5 (1.8%) | 0.261 |
Nausea/vomiting | 24 (5.5%) | 6 (3.6%) | 18 (6.6%) | 0.169 |
Diarrhea | 69 (15.7%) | 31 (18.5%) | 38 (14%) | 0.215 |
Neurological symptoms, n (%) | 192 (43.8%) | 74 (44%) | 118 (43.5%) | 0.917 |
Headache | 83 (18.9%) | 27 (16.1%) | 56 (20.7%) | 0.232 |
Dizziness | 63 (14.4%) | 27 (16.1%) | 36 (13.3%) | 0.418 |
Vertigo | 3 (0.7%) | 1 (0.6%) | 2 (0.7%) | 0.860 |
Loss of smell | 35 (8%) | 15 (8.9%) | 20 (7.4%) | 0.560 |
Loss of taste | 25 (5.7%) | 10 (6%) | 15 (5.5%) | 0.854 |
CT-chest findings, n (%) | ||||
Normal | 16 (4.9%) | 10 (9.2%) | 6 (2.8%) | 0.124 |
Bilateral GGO | 270 (82.6%) | 87 (79.8%) | 183 (83.9%) | |
Unilateral GGO | 5 (1.5%) | 2 (1.8%) | 3 (1.4%) | |
GGO and consolidations | 36 (11%) | 10 (9.2%) | 26 (12%) | |